Cancer Targeted Therapy

Cancer targeted therapy focuses on drugs designed to identify and attack specific molecular targets involved in cancer cell growth and survival. Unlike conventional chemotherapy, which can harm both cancerous and healthy cells, targeted therapies are more precise, aiming to reduce collateral damage to normal cells. Key molecules targeted include tyrosine kinases, VEGF, and other receptors that drive tumor proliferation. Examples like Afatinib and Osimertinib target specific mutations in cancers such as lung and breast cancer, enhancing treatment efficacy and minimizing side effects. These therapies block cell signals that allow cancer cells to multiply, cutting off their ability to sustain abnormal growth. Targeted therapy’s specificity means fewer side effects and improved patient quality of life. Ongoing research in this field aims to identify new molecular targets, create more refined drugs, and broaden treatment applications across diverse cancer types, offering a promising approach to personalized cancer treatment.